Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort

Pipek, Orsolya and Alpár, Donát and Rusz, Orsolya and Bödör, Csaba and Udvarnoki, Zoltán and Medgyes-Horváth, Anna and Csabai, István and Szállási, Zoltán and Madaras, Lilla and Kahán, Zsuzsanna and Cserni, Gábor and Kővári, Bence and Kulka, Janina and Tokes, Anna Mária (2023) Genomic Landscape of Normal and Breast Cancer Tissues in a Hungarian Pilot Cohort. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 24 (10). No-8553. ISSN 1661-6596

Preview

Text Pipek_IJMS_2023.pdf - Published Version Available under License Creative Commons Attribution. Download (2MB) | Preview

Abstract

A limited number of studies have focused on the mutational landscape of breast cancer in different ethnic populations within Europe and compared the data with other ethnic groups and databases. We performed whole-genome sequencing of 63 samples from 29 Hungarian breast cancer patients. We validated a subset of the identified variants at the DNA level using the Illumina TruSight Oncology (TSO) 500 assay. Canonical breast-cancer-associated genes with pathogenic germline mutations were CHEK2 and ATM. Nearly all the observed germline mutations were as frequent in the Hungarian breast cancer cohort as in independent European populations. The majority of the detected somatic short variants were single-nucleotide polymorphisms (SNPs), and only 8% and 6% of them were deletions or insertions, respectively. The genes most frequently affected by somatic mutations were KMT2C (31%), MUC4 (34%), PIK3CA (18%), and TP53 (34%). Copy number alterations were most common in the NBN, RAD51C, BRIP1, and CDH1 genes. For many samples, the somatic mutational landscape was dominated by mutational processes associated with homologous recombination deficiency (HRD). Our study, as the first breast tumor/normal sequencing study in Hungary, revealed several aspects of the significantly mutated genes and mutational signatures, and some of the copy number variations and somatic fusion events. Multiple signs of HRD were detected, highlighting the value of the comprehensive genomic characterization of breast cancer patient populations.

Actions (login required)

Edit Item